Judgment of the General Court (Sixth Chamber) of 11 July 2013 —
Aventis Pharmaceuticals v OHIM — Fasel (CULTRA)

(Case T‑142/12)

Community trade mark — Opposition proceedings — Application for Community figurative trade mark CULTRA — Earlier national word marks SCULPTRA — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009

1.                     Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Assessment of the likelihood of confusion — Criteria (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 22, 53)

2.                     Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Figurative mark CULTRA and word marks SCULPTRA (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 27, 51, 52, 56, 57)

Re:

ACTION brought against the decision of the First Board of Appeal of OHIM of 26 January 2012 (Case R 2478/2010‑1) relating to opposition proceedings between Aventis Pharmaceuticals, Inc. and Fasel Srl.

Operative part

The Court:

1. Annuls the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) of 26 January 2012 (Case R 2478/2010‑1);

2. Dismisses the remainder of the action;

3. Orders OHIM to pay its own costs and those of Aventis Pharmaceuticals, Inc., for the purposes of the proceedings before the General Court and of those before the Board of Appeal.